UBS Group AG - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 35 filers reported holding SAB BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,939
-28.1%
6,679
-3.6%
0.00%
Q4 2022$4,087
+308.7%
6,927
+360.6%
0.00%
Q3 2022$1,0000.0%1,504
+50.4%
0.00%
Q2 2022$1,000
-83.3%
1,000
-28.9%
0.00%
Q1 2022$6,000
-87.2%
1,407
-76.4%
0.00%
Q4 2021$47,0005,9530.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 78,115$294,0000.05%
Shaolin Capital Management LLC 275,000$1,034,0000.03%
Spectrum Management Group, LLC 5,030$19,0000.00%
Veritable, L.P. 43,551$164,0000.00%
ALPS ADVISORS INC 45,083$170,0000.00%
ETF MANAGERS GROUP, LLC 13,187$34,0000.00%
Qube Research & Technologies Ltd 24,179$91,0000.00%
NORTHERN TRUST CORP 44,476$167,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 301,110$1,132,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders